Preview Mode Links will not work in preview mode

GRACEcast


Jan 19, 2016

Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melanoma.